This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Oxcarbazepine in Bipolar Disorder

James W. Jefferson, MD

Published: August 1, 2001

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Dr. Berigan’s otherwise thorough overview of neweranticonvulsants in psychiatry1 requires comment with regard tooxcarbazepine. The first double-blind study was placebo controlledand published in 1983, not 1985.2 Six rather than 7 patientswere involved (1 was treated on 2 occasions, making atotal of 7 trials) in an A-B-A crossover design of unspecifiedduration with a mean improvement in Inpatient MultidimensionalPsychiatric Scale scores of 49.9%, not 86%.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 3

Quick Links: